ロード中...
Poly(ADP‐ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer
BACKGROUND: Ovarian cancer is the sixth most common cancer and seventh most common cause of cancer death in women world‐wide. Three‐quarters of women present when the disease has spread throughout the abdomen (stage III or IV) and treatment consists of a combination of debulking surgery and platinum...
保存先:
| 出版年: | Cochrane Database Syst Rev |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6457589/ https://ncbi.nlm.nih.gov/pubmed/25991068 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007929.pub3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|